• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution• Commercial launch expected the week of June 2nd• Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE ...

Dr. Nijm discussed her ASCRS presentation, focused on a study of hyperosmolarity's impact on cataract surgery outcomes. "Hyperosmolarity induces light scatter that's equivalent to a grade 2 to 3 ...

imageimageA cAMP-regulated ribonucleoprotein network controlled by the RING ligase praja2 regulates DDX6/mRNA complex formation, P-body assembly and protein translation in human glioblastoma. praja2 ...

Tear film instability associated with MGD leads to tear hyperosmolarity, resulting in apoptosis and inflammation of the ocular surface. Patients suffering from DED complain of symptoms including ...

Diabetes is a metabolic condition defined by consistently elevated blood glucose levels. Hyperglycemia is characterized by heightened hunger, thirst, and urination. Numerous consequences may arise ...

"Studies show that if you read for 30 minutes silently and you have dry eye disease, you'll read 28 words-per-minute slower," ...

In hyperosmolarity-induced DED corneal epithelial cells, AST increased the expression of ferritin to promote iron storage and reduce Fe 2+ overload. It increased glutathione (GSH) and GPX4, scavenged ...

Causes Of Excessive Thirst At Night Medically referred to as polydipsia, extreme thirst can have several causes. It is characterised by a dry mouth, an abnormal urge to drink fluids all the time ...

Bausch + Lomb has acquired Trukera Medical in an effort to expand its position in dry eye care, according to a press release. Bausch’s announcement highlighted Trukera’s ScoutPro ...

Commercially-available eye drops can improve the hyperosmolarity of the ocular surface and reduce inflammation in individuals with dry eye disease (DED), according to study published in Cornea.

“Dry eye” is a multifactorial inflammatory disease affecting the ocular surface. Tear hyperosmolarity in dry eye contributes to inflammation and cell damage. Recent research efforts on dry eye have ...

PL9643 ophthalmic solution is a melanocortin agonist with a novel mechanism of action that produced a clinically meaningful and statistically significant reduction in pain associated with dry eye ...